GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (OTCPK:DHTRF) » Definitions » Valuation Rank

DHTRF (DRI Healthcare Trust) Valuation Rank


View and export this data going back to 2023. Start your Free Trial

What is DRI Healthcare Trust Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

DRI Healthcare Trust Valuation Rank Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

DRI Healthcare Trust Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (OTCPK:DHTRF) » Definitions » Valuation Rank
Comparable Companies
TSX:GUD NEOE:GLAS.A.U XCNQ:CL TSX:ACB NEOE:VRNO TSX:CPH TSX:CRON XCNQ:VREO XCNQ:TRUL TSX:WEED ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
DHT.UN:Canada DHT.U:Canada
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
Website
https://www.dricapital.com
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.